Correlation Engine 2.0
Clear Search sequence regions

  • human (5)
  • liquid (1)
  • mass (2)
  • patients (1)
  • phase (1)
  • serum (7)
  • volunteers (1)
  • Sizes of these terms reflect their relevance to your search.

    Several metabolites in human serum have been identified as potential cancer biomarkers for early detection. This study focuses on the LC-MS/MS method development and validation of d-mannose in human serum. Surrogate blank serum, coupled with stable isotope d-mannose-13C6, as internal standard, was used for generating standard curves ranging from 1 to 50μg/mL. Separation was achieved by an Agilent 1200 series HPLC equipped with a SUPELCOGELTM Pb, 6% Crosslinked column with HPLC water as a mobile phase at flow rate of 0.5mL/min at 80°C. Mass detection was performed under negative ionization electrospray. Inter- and intra-day accuracy and precision were <2%. The extraction recovery and matrix effect were 104.1%-105.5% and 97.0%-100.0%, respectively. This method was successfully applied for the quantification of d-mannose in the serum samples of 320 esophageal cancer patients and 323 healthy volunteers. We report a simple, specific and reproducible LC-MS/MS method for the quantification of d-mannose in human serum as a potential cancer biomarker. Copyright © 2016 Elsevier B.V. All rights reserved.


    Lyndsey White, Jing Ma, Su Liang, Beatriz Sanchez-Espiridion, Dong Liang. LC-MS/MS determination of d-mannose in human serum as a potential cancer biomarker. Journal of pharmaceutical and biomedical analysis. 2017 Apr 15;137:54-59

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 28092855

    View Full Text